Delivery Order SPE2DB22D3501-SPE2DB25FXA51
- Not listed
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This competitive, firm fixed-price delivery order carries a ceiling value of $8,528.34 and is due for completion by August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award carries no set-aside designation,...
- The Defense Logistics Agency awarded a $25,585.02 delivery order to AmerisourceBergen Drug Corp for VYVGART (efgartigimod) 400 mg/20 ml vials on August 18, 2025, with a completion deadline of September 9, 2025. This firm fixed-price order represents a competitively awarded, non-set-aside contract for the supply of this specialty pharmaceutical product to support military and federal healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials on October 28, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialty pharmaceutical product used in the treatment of autoimmune...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for Vyvgart 400 mg/20 mL vials on October 20, 2025, with completion expected by November 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialized pharmaceutical product used in the treatment of autoimmune conditions, reflecting...
- The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 ml vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of VYVGART 400 mg/20 ml vials with a ceiling value of $38,377.53. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition in accordance with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of June 18, 2025. The contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXA51Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Vyvgart (efgartigimod) 400 mg/20 mL vials, a specialty pharmaceutical product used in treating autoimmune conditions. This competitively awarded, non-set-aside contract carries a ceiling value of $8,528.34 with firm fixed pricing and a completion date of September 17, 2025. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery order represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies—including specialty medications, branded and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The company's role as a critical pharmaceutical distributor to the Defense Health Agency and other federal healthcare systems demonstrates its significance within the military medical supply chain and the broader Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/26/25 |